Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Deoxynucleosides Pyrimidines as Treatment for Mitochondrial Depletion Syndrome — Stella

Home/Mitochondrial Diseases/

View on ClinicalTrials.gov

Recruiting

Back to Mitochondrial Diseases trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

Canada

Research InstituMcGill University Health Centre - Children Hospital of Montreal, Montreal, Quebec

Key details

Phase

Safety & dosing

Sponsor

Kenneth Myers, MD

Enrollment target

~200 participants

Started

October 2021

Primary completion

June 2029

Age range

1 Month – 60 Years

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.